Accuray (ARAY) Announces Submission of Radixact Treatment Delivery System 510(k) App to FDA
Tweet Send to a Friend
Accuray Incorporated (NASDAQ: ARAY) announced the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
